Increased Post-Kidney Transplant Risks Associated with BMI-BSA Obesity
Obesity defined by combined BMI and BSA metrics increases the risk of adverse outcomes after kidney transplantation, highlighting the need for accurate assessment methods for better patient management.
Recent research indicates that obesity defined through combined body mass index (BMI) and body surface area (BSA) metrics significantly elevates the risk of adverse outcomes following kidney transplantation. A comprehensive study analyzing data from over 242,000 adult kidney transplant recipients across the United States found that patients categorized as obese by both BMI and BSA exhibited notably higher risks of graft loss, delayed graft function, and overall mortality. Specifically, the adjusted hazard ratios pointed to a 23% increased risk of death-censored graft loss, 9% higher for all-cause graft loss, and 58% greater likelihood of delayed graft function when obesity was confirmed by both measures. Interestingly, patients with discordant BMI and BSA obesity classifications demonstrated a lower risk profile compared to those classified as obese by both metrics. These findings suggest that combining BMI and BSA assessments provides a more accurate prediction of post-transplant risks and should guide clinical evaluation for transplantation candidates. This study underscores the importance of precise obesity evaluation in transplant planning to improve patient outcomes.
Source: https://medicalxpress.com/news/2025-05-kidney-transplant-adverse-outcomes-bmi.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Impact of Abortion Bans on Maternal Mortality and Health Risks
New research forecasts increased maternal mortality and health risks following abortion bans in the US, emphasizing ongoing disparities and healthcare challenges.
Enhancing Rural Endocrinology Care Through Telemedicine: New Study Highlights Positive Impact
A new study shows how telemedicine has improved access to endocrinology care for rural patients, reducing disparities and enhancing health outcomes during the COVID-19 pandemic.
Guidelines Recommend SGLT-2 and GLP-1 Therapies Primarily for Adults at Elevated Risk of Heart and Kidney Issues
New international guidelines recommend using SGLT-2 inhibitors and GLP-1 receptor agonists mainly for adults with type 2 diabetes at moderate or high risk of heart and kidney complications, supporting personalized treatment approaches.
Innovative Deep Learning Model Enhances Prediction of Microsatellite Instability in Cancer Tumors
A novel deep learning model from Yonsei University accurately predicts microsatellite instability in tumors and assesses uncertainty to enhance clinical decision-making, supporting personalized cancer therapies.